|
|
 |
|
|
 |
|
|
|
 |
|
|
|
|
|
Select from the links below:
|
|
|
Publications alphabetically by author:
|
|
|
|
|
|
|
|
|
|
J-O
|
|
|
Jalal H., Bibby D.F., Tang J., Bennett J., Kyriakou C., Pegg K., Cubitt W.D., Brink N.S., Ward K.N. & Tedder R.S. (2005). First reported outbreak of diarrhoea due to adenovirus infection in a haematology unit for adults. Journal of Clinical Microbiology 43:2575-2580.
|
Jazayeri M.S., Basuni A.A., Cooksley G., Locarnini S., Carman WF. (2004). Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region. Journal of Hepatology 41:139-146.
|
Jazayeri M., Basuni A.A., Sran N., Gish R., Cooksley G., Locarnini S. & Carman WF. (2004). HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. Journal of Viral Hepatitis 11:488-501.
|
Jazayeri M.S., Dornan E.S., Boner W., Fattovich G., Hadziyannis S. & Carman W.F. (2004). Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern. The Journal of Infectious Diseases 189:1634-1645.
|
Kampmann B., Cubitt D., Walls T., Naik P., Depala M., Samarasinghe S., Robson D., Hassan A., Rao K., Gaspar H., Davies G., Jones A., Cale C., Gilmour K., Real M., Foo M., Bennett-Rees N., Hewitt A., Amrolia P. & Veys P. (2005). Improved outcome for children with adenoviraemia following allogeneic stem cell transplantation. British Journal of Haematology 130:595-603.
|
Kantor R, Katzenstein D.A., Efron B., Carvalho A.P., Wynhoven B., Cane P., et al. (2005). Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. Public Library of Science Medicine 2:e112.
|
Khare M., Sharland M., Manyonda I., Rice P., Bland J.M. & Griffiths P. (2004). Use of serial maternal urine cytomegalovirus PCR to detect primary CMV infection in seronegative pregnant women. Journal of Virological Methods 119(1):31-35.
|
Khot A., Dignan F., Taylor S. Potter M., Cubitt W.D. & Treleavan J.G. (2006). Another case of PORN (bilaterally, progressive outer retinal necrosis) after allogeneic stem cell transplantation. Bone Marrow Transplantation 37(1):113-114.
|
Ljungman P., Reusser P., de la Cámara R., Einsele H., Engelhard D., Ribaud P., Ward K. & Cordonnier C. - for the infectious diseases working party of the EBMT. (2004). Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplantation 33:1075-1081.
|
Ljungman P., Engelhard D., de la Cámara R., Einsele H., Locasciulli A., Martino R., Ribaud P., Ward K. & Cordonnier C. - for the infectious diseases working party of the EBMT. (2005). Vaccination of stem cell transplant recipients: recommendations of the infectious diseases working Party of the EBMT. Bone Marrow Transplantation 35:737-746.
|
Maclennan C., Dunn G., Huisson A.P., Kumararatne D.S., Martin J., O’Leary P., Thompson R.A., Osman H., Wood P., Minor P., Wood D.J. & Pillay D. (2004). Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363(9420):1509-1513.
|
Mattes F.M., Hainsworth E.G., Geretti A.M., Nebbia G., Prentice G., Potter M., Burroughs A.K., Sweny P., Hassan-Walker A.F., Okwuadi A., Sabin S., Amooty G., Brown V.S., Grace S.C., Emery V. & Griffiths P.D. (2004). A Randomized, Controlled Trial Comparing Ganciclovir to Ganciclovir Plus Foscarnet (Each at Half Dose) for Pre-emptive Therapy of Cytomegalovirus Infection in Transplant Recipients. Journal of Infectious Diseases 189:1355-1361.
|
McCann S., Byrne J.L., Rovira M., Shaw P., Ribaud P., Sica S., Volin L., Olavarria E., Mackinnon S., Trabasso P., van Lint M.T., Ljungman P, Ward K., Browne P., Gratwohl A., Widmer A.F. & Cordonnier C. - for the Infectious Disease Working Party of the EBMT. (2004). Outbreaks of infectious disease in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplantation 33:519-530.
|
McCaughey C., Murray L.J., McKenna J.P., Coyle P.V., O'Neill H.J., Wyatt D.E., Woodside J.V., Yarnell J.W., Ducimetiere P., Bingham A., Amouyel P., Montaye M., Arveiler D., Haas B., Ferrieres .J & Ruidavets J.B. (2005). Lack of association between serological evidence of past Coxiella burnetii infection and incident ischaemic heart disease: nested case-control study. BMC Infectious Diseases 20(5):61.
|
McManus T.E., Coyle P.V. & Kidney J.C. Childhood respiratory infections and hospital admissions for COPD. Respiratory Medicine 2005 Jul 23; [Epublished ahead of print].
|
Moore C., Clark E.M., Gallimore C.I., Corden S.A., Gray J.J. & Westmoreland D. (2004). Evaluation of a broadly reactive nucleic acid sequence based amplification assay for the detection of noroviruses in faecal material. Journal of Clinical Virology 29:290–296.
|
Moore C., Hibbitts S, Owen N., Corden S.A., Harrison, G. Fox J, Gelder C. & Westmoreland D. (2004). Development and evaluation of a real-time nucleic acid sequence based amplification assay for rapid detection of influenza A. Journal of Medical Virology 74:619-628.
|
Nebbia G., Chawla A., Schutten M., Atkinson C., Raza M., Johnson M. & Geretti AM. (2005). Adenovirus viraemia and dissemination unresponsive to antiviral therapy in advanced HIV-1 infection. AIDS 19:1339-1340.
|
Nokes D.J., Okiro E.A., Ngama M., White L.J., Ochola R., Scott P.D., Cane P.A. & Medley, G.F. (2004). RSV epidemiology in a birth cohort in Kilifi District, Kenya: infection in the first year of life. Journal of Infectious Diseases 190:1828-1832.
|
O’Shea, M. & Cane P.A. (2004). Development of a highly sensitive semi-quantitative real-time PCR and molecular beacon probe assay for the detection of respiratory syncytial virus. Journal of Virological Methods 118:101-110.
|
Ong G.M., Lowry K., Mahajan S., Wyatt D.E., Simpson C., O'Neill H.J., McCaughey C. & Coyle P.V. (2004). Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit. Journal of Medical Virology 72(1):121-125.
|
Opi S., Peloponese Jr. J-M., Esquieu D., Watkins J., Campbell G., De Mareuil J., Jeang K.T., Yirrell D.L., Kaleebu P. & Loret E.P. (2004). Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine 22:3105-3111.
|
|
|
|
|
|
|
NB. Adobe Acrobat Reader is required to read pdf files.If you don't have a copy
of Adobe Acrobat Reader it can be downloaded by following the link below.
|
|
|
 |
|
|
|
|
|
 |
|
|
Use the pop up menu below to access a laboratory in your area:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
